These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36685570)

  • 1. Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
    Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
    Front Immunol; 2022; 13():1124440. PubMed ID: 36685570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
    Shirane M; Yawata N; Motooka D; Shibata K; Khor SS; Omae Y; Kaburaki T; Yanai R; Mashimo H; Yamana S; Ito T; Hayashida A; Mori Y; Numata A; Murakami Y; Fujiwara K; Ohguro N; Hosogai M; Akiyama M; Hasegawa E; Paley M; Takeda A; Maenaka K; Akashi K; Yokoyama WM; Tokunaga K; Yawata M; Sonoda KH
    Front Immunol; 2022; 13():1008220. PubMed ID: 36341392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis.
    Vietzen H; Rückert T; Hartenberger S; Honsig C; Jaksch P; Geleff S; Hammer Q; Romagnani C; Segura-Wang M; Puchhammer-Stöckl E
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.
    Tarragó D; González I; González-Escribano MF
    BMC Genomics; 2022 Jun; 23(1):455. PubMed ID: 35725386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
    Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
    J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.
    Prod'homme V; Tomasec P; Cunningham C; Lemberg MK; Stanton RJ; McSharry BP; Wang EC; Cuff S; Martoglio B; Davison AJ; Braud VM; Wilkinson GW
    J Immunol; 2012 Mar; 188(6):2794-804. PubMed ID: 22345649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.
    Sullivan LC; Westall GP; Widjaja JM; Mifsud NA; Nguyen TH; Meehan AC; Kotsimbos TC; Brooks AG
    PLoS One; 2015; 10(8):e0135972. PubMed ID: 26302084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation.
    Jeon S; Lee WK; Lee Y; Lee DG; Lee JW
    Ophthalmology; 2012 Sep; 119(9):1892-8. PubMed ID: 22657564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA; Gao D; Springer KL; Patterson JA; Brunvand MW; McSweeney PA; Zeng C; Barón AE; Weinberg A
    Clin Infect Dis; 2009 Dec; 49(12):1777-83. PubMed ID: 19911937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    Vietzen H; Hartenberger S; Jaksch P; Puchhammer-Stöckl E
    J Heart Lung Transplant; 2021 Sep; 40(9):900-904. PubMed ID: 34183227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell receptors regulate responses of HLA-E-restricted T cells.
    Sullivan LC; Nguyen THO; Harpur CM; Stankovic S; Kanagarajah AR; Koutsakos M; Saunders PM; Cai Z; Gray JA; Widjaja JML; Lin J; Pietra G; Mingari MC; Moretta L; Samir J; Luciani F; Westall GP; Malmberg KJ; Kedzierska K; Brooks AG
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes.
    Pietra G; Romagnani C; Mazzarino P; Falco M; Millo E; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10896-901. PubMed ID: 12960383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV-Specific Immune Response-New Patients, New Insight: Central Role of Specific IgG during Infancy and Long-Lasting Immune Deficiency after Allogenic Stem Cell Transplantation.
    Zdziarski P
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.
    Tomasec P; Braud VM; Rickards C; Powell MB; McSharry BP; Gadola S; Cerundolo V; Borysiewicz LK; McMichael AJ; Wilkinson GW
    Science; 2000 Feb; 287(5455):1031. PubMed ID: 10669413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.